trans-3-(4-fluorophenyl)-prop-2-en-1-yl-(2-tetrahydropyranyl)ether

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: trans-3-(4-fluorophenyl)-prop-2-en-1-yl-(2-tetrahydropyranyl)ether
• 英文别名: (E)-1-(4-fluorophenyl)-3-(tetrahydropyran-2-yloxy)propene；2-[(E)-3-(4-fluorophenyl)prop-2-enoxy]oxane
• 化学式: C₁₄H₁₇FO₂
• 分子量: 236.286
• InChiKey: LMURPMWGMMCWOE-ONEGZZNKSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.2
• 重原子数：
  17
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.43
• 拓扑面积：
  18.5
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  trans-3-(4-fluorophenyl)-prop-2-en-1-yl-(2-tetrahydropyranyl)ether 在 sodium azide 、 一氯化碘 作用下， 以 乙腈 为溶剂， 反应 20.0h， 生成 erythro-3-azido-3-(4-fluorophenyl)-2-iodoprop-1-yl-(2-tetrahydropyranyl)ether
  参考文献：
  名称：

  Synthesis and In Vitro Pharmacological Behavior of Platinum(II) Complexes Containing 1,2-Diamino-1-(4-fluorophenyl)-2-alkanol Ligands

  摘要：

  In continuation of our effort to optimize the pharmacological profile of [1,2-diamino-1,2-bis(4-fluorophenyl)ethane]dichloridoplatinum(II) complexes, we synthesized [1,2-diamino-1-(4-fluorophenyl)alkanol]dichloridoplatinum(II) analogs. The aim of this study was to evaluate the influence of hydroxyl groups at the C2 moiety on aqueous solubility, lipophilicity, cellular platinum accumulation, and cytotoxicity against MDA-MB-231, U-937, RAJI, and SC-1 cells as well as against cisplatin-sensitive and cisplatin-resistant A2780 and A2780cisR ovarian carcinoma cells. As expected, the OH groups improved the water solubility and decreased the lipophilicity of the neutral ligands, resulting in complexes with favorable pharmacokinetic properties. The cellular uptake of the compounds in MDA-MB-231 and U-937 cells proved to depend on the configuration and showed only a slight correlation with lipophilicity. The most active complexes were R,R/S,S configured, which points to a carrier-mediated mode of action. [threo-1,2-Diamino-1-(4-fluorophenyl)propan]dichloridoplatinum(II) and [threo-2,3-diamino-3-(4-fluorophenyl)propan-1-ol]dichloridoplatinum(II) possessed only low cross-resistance to cisplatin and were up to 10-fold more active in lymphoma cell lines.

  DOI：

  10.1021/jm400967z
• 作为产物：
  描述：

  氟肉桂酸 在 aluminum (III) chloride 、 lithium aluminium tetrahydride 、 4-甲基苯磺酸吡啶 作用下， 以 乙醚 、 二氯甲烷 为溶剂， 反应 4.5h， 生成 trans-3-(4-fluorophenyl)-prop-2-en-1-yl-(2-tetrahydropyranyl)ether
  参考文献：
  名称：

  Synthesis and In Vitro Pharmacological Behavior of Platinum(II) Complexes Containing 1,2-Diamino-1-(4-fluorophenyl)-2-alkanol Ligands

  摘要：

  In continuation of our effort to optimize the pharmacological profile of [1,2-diamino-1,2-bis(4-fluorophenyl)ethane]dichloridoplatinum(II) complexes, we synthesized [1,2-diamino-1-(4-fluorophenyl)alkanol]dichloridoplatinum(II) analogs. The aim of this study was to evaluate the influence of hydroxyl groups at the C2 moiety on aqueous solubility, lipophilicity, cellular platinum accumulation, and cytotoxicity against MDA-MB-231, U-937, RAJI, and SC-1 cells as well as against cisplatin-sensitive and cisplatin-resistant A2780 and A2780cisR ovarian carcinoma cells. As expected, the OH groups improved the water solubility and decreased the lipophilicity of the neutral ligands, resulting in complexes with favorable pharmacokinetic properties. The cellular uptake of the compounds in MDA-MB-231 and U-937 cells proved to depend on the configuration and showed only a slight correlation with lipophilicity. The most active complexes were R,R/S,S configured, which points to a carrier-mediated mode of action. [threo-1,2-Diamino-1-(4-fluorophenyl)propan]dichloridoplatinum(II) and [threo-2,3-diamino-3-(4-fluorophenyl)propan-1-ol]dichloridoplatinum(II) possessed only low cross-resistance to cisplatin and were up to 10-fold more active in lymphoma cell lines.

  DOI：

  10.1021/jm400967z

文献信息

• Heck Reaction of Protected Allyl Alcohols with Aryl Bromides Catalyzed by a Tetraphosphanepalladium Complex
  作者：Florian Berthiol、Henri Doucet、Maurice Santelli

  DOI：10.1002/ejoc.200400797

  日期：2005.4

  A range of aryl bromides undergo a Heck vinylation reaction with a protected allyl alcohol in the presence of[PdCl(C3H5)]2/cis,cis,cis-1,2,3,4-tetrakis(diphenylphosphan-ylmethyl)cyclopentane as a catalyst. The reactivity of these allyl alcohol derivatives using a variety of protecting groups has been studied. The best results in terms of substrate/catalyst ratio were obtained with a THP protecting

  在[PdCl(C3H5)]2/cis,cis,cis-1,2,3,4-四(二苯基膦基甲基)环戊烷存在下，一系列芳基溴化物与受保护的烯丙醇发生Heck乙烯基化反应催化剂。已经研究了使用各种保护基团的这些烯丙醇衍生物的反应性。使用 THP 保护基团获得了在底物/催化剂比方面的最佳结果。在大多数情况下，获得的主要异构体是 (E)-肉桂醇衍生物。该反应耐受多种官能团，例如三氟甲基、甲氧基、二甲氨基、乙酰基、甲酰基或腈。此外，这种催化剂可以在低负载下使用，甚至可以用于与空间位阻底物的反应。(© Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2005)
• Synthesis and In Vitro Pharmacological Behavior of Platinum(II) Complexes Containing 1,2-Diamino-1-(4-fluorophenyl)-2-alkanol Ligands
  作者：Irene Würtenberger、Bernhard Angermaier、Brigitte Kircher、Ronald Gust

  DOI：10.1021/jm400967z

  日期：2013.10.24

  In continuation of our effort to optimize the pharmacological profile of [1,2-diamino-1,2-bis(4-fluorophenyl)ethane]dichloridoplatinum(II) complexes, we synthesized [1,2-diamino-1-(4-fluorophenyl)alkanol]dichloridoplatinum(II) analogs. The aim of this study was to evaluate the influence of hydroxyl groups at the C2 moiety on aqueous solubility, lipophilicity, cellular platinum accumulation, and cytotoxicity against MDA-MB-231, U-937, RAJI, and SC-1 cells as well as against cisplatin-sensitive and cisplatin-resistant A2780 and A2780cisR ovarian carcinoma cells. As expected, the OH groups improved the water solubility and decreased the lipophilicity of the neutral ligands, resulting in complexes with favorable pharmacokinetic properties. The cellular uptake of the compounds in MDA-MB-231 and U-937 cells proved to depend on the configuration and showed only a slight correlation with lipophilicity. The most active complexes were R,R/S,S configured, which points to a carrier-mediated mode of action. [threo-1,2-Diamino-1-(4-fluorophenyl)propan]dichloridoplatinum(II) and [threo-2,3-diamino-3-(4-fluorophenyl)propan-1-ol]dichloridoplatinum(II) possessed only low cross-resistance to cisplatin and were up to 10-fold more active in lymphoma cell lines.